Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Two Way Crossover Closed Loop Study R-AP vs MPC [NA]
A completed two-way crossover closed-loop study comparing R-AP and MPC in individuals with Type 1 Diabetes; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Role of Alpha-lipoic Acid in Diabetes Melitus Type 1 [Phase 3]
Phase 3 trial evaluating alpha-lipoic acid in Type 1 diabetes mellitus; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes [Phase 2]
Phase 2 trial evaluating Diamyd administered into lymph nodes with vitamin D in type 1 diabetes has completed with results posted in 2023.
-
CLINICAL_TRIALS research · 2022-12-21Clinical Trial Update: Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD). [NA]
A completed clinical trial evaluating the accuracy of continuous glucose monitoring in patients with end-stage renal disease on intermittent…
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas [Phase 2, Phase 3]
A Phase 2/3 trial evaluating individualized pharmacokinetic profiling to automate insulin-only closed-loop glucose control in a bionic pancr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-12-08FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk, resulting in labeling changes related to the pr…
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery [NA]
This clinical trial about Adaptive Biobehavioral Control (ABC) for automated insulin delivery in Type 1 Diabetes Mellitus has completed, wit…
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 [NA]
Completed protocol update for the International Diabetes Closed Loop (iDCL) Trial; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: The International Diabetes Closed Loop (iDCL) Trial: Protocol 4 [NA]
A completed clinical trial update for the International Diabetes Closed Loop (iDCL) Trial: Protocol 4 in Type 1 Diabetes with results posted…
-
FDA approval · 2022-11-30FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) filed by Sanofi‑Aventis U.S. LLC.
-
FDA approval · 2022-11-23FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes [NA]
Clinical trial update on the efficacy of inControl Advice, a decision support system for diabetes, with completed status and posted results.
-
FDA approval · 2022-11-17FDA Approved: TZIELD — Original Application (Provention Bio, Inc.)
The FDA approved TZIELD (teplizumab-mzwv) in an original Biologics License Application to delay the onset of stage 3 type 1 diabetes in indi…
-
FDA approval · 2022-11-16FDA Approved: REZVOGLAR KWIKPEN — Original Application (Eli Lilly and Company)
FDA approved Rezvoglar KwikPEN (insulin glargine-AGLR) from Eli Lilly as a biosimilar insulin glargine via an Original Application. It is in…
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients [Phase 4]
A Phase 4 trial comparing glucose values and variability between TOUJEO and TRESIBA during continuous glucose monitoring in adults with type…
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and diabetes status during oral GABA treatment in patients with longstanding Type 1 Diabete…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients [NA]
A trial update on using an artificial pancreas system in older adults with type 1 diabetes mellitus; study is terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: A Study of LY3209590 in Participants With Type 1 Diabetes [Phase 2]
Phase 2 clinical trial update for LY3209590 in participants with Type 1 Diabetes mellitus has completed with results posted.
-
FDA approval · 2022-10-14FDA Approved: LYUMJEV — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for LYUMJEV (insulin lispro-aabc) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Adolescent Interventions to Manage Self-regulation of T1D (AIMS T1D) [NA]
A completed clinical trial (AIMS T1D) evaluating adolescent interventions to manage self-regulation and medication adherence in type 1 diabe…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D [NA]
A completed clinical trial comparing closed-loop versus standard SAP therapy for hypoglycemia reduction in individuals with Type 1 Diabetes …
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes [Phase 2]
Phase 2 trial evaluating pen-administered low-dose dasiglucagon for prevention and treatment of hypoglycemia in people with type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: MiniMed™ 670G System China Study for Type I Diabetic [NA]
Clinical trial update for the MiniMed 670G System in China for Type 1 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management [Phase 4]
A Phase 4 trial investigating early basal insulin administration in adult diabetic ketoacidosis management; the study was terminated with re…
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension) [NA]
A completed clinical trial update for the iDCL Trial (DCLP3 Extension) involving an artificial pancreas for Type 1 diabetes; results posted …